Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma
Open Access
- 30 May 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 30 (48), 4814-4823
- https://doi.org/10.1038/onc.2011.189
Abstract
Translational control at the initiation step has been recognized as a major and important regulatory mechanism of gene expression. Eukaryotic initiation factor-3a (eIF3a), a putative subunit of the eIF3 complex, has recently been shown to have an important role in regulating the translation of a subset of mRNAs and is found to correlate with the prognosis of cancers. In this study, using nasopharyngeal carcinoma (NPC) cells as a model system, we tested the hypothesis that eIF3a negatively regulates the synthesis of nucleotide excision repair (NER) proteins, and, in turn, cellular response to treatments with DNA-damaging agents such as cisplatin (cis-dichlorodiammine platinum(II) (CDDP)). We found that a CDDP-sensitive sub-clone S16 isolated through limited dilution from an NPC cell line CNE-2 has increased eIF3a expression. Knocking down its expression in S16 cells increased cellular resistance to CDDP, NER activity and synthesis of the NER proteins XPA, XPC, RAD23B and RPA32. Altering eIF3a expression also changed the cellular response to CDDP and UV treatment in other NPC cell lines. Taken together, we conclude that eIF3a has an important role in the CDDP response and in NER activity of NPCs by suppressing the synthesis of NER proteins.Keywords
This publication has 39 references indexed in Scilit:
- Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancersBMC Cancer, 2010
- Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatmentsBioscience Reports, 2010
- Identification of Novel Small Molecule Inhibitors of the XPA Protein Using in Silico Based ScreeningACS Chemical Biology, 2010
- Photo-Cross-Linking of XPC−Rad23B to Cisplatin-Damaged DNA Reveals Contacts with Both Strands of the DNA Duplex and Spans the DNA AdductBiochemistry, 2009
- A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproductionMolecular Cancer Therapeutics, 2008
- Oligomerization Domain of the Multidrug Resistance–Associated Transporter ABCG2 and Its Dominant Inhibitory ActivityCancer Research, 2007
- Regulation of Function by Dimerization through the Amino-terminal Membrane-spanning Domain of Human ABCC1/MRP1Journal of Biological Chemistry, 2007
- p150 Overexpression in gastric carcinoma: The association with p53, apoptosis and cell proliferationInternational Journal of Cancer, 2004
- Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growthOncogene, 2004
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003